AMIX
HEALTHCAREAutonomix Medical Inc
$0.38+0.01 (+1.58%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving AMIX Today?
No stock-specific AI insight has been generated for AMIX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.32$2.64
$0.38
Fundamentals
Market Cap$4M
P/E Ratio—
EPS$-3.15
Dividend Yield—
Dividend / Share—
ROE-1.9%
Profit Margin—
Debt / Equity—
Trading
Volume85K
Avg Volume (10D)—
Shares Outstanding11.4M
AMIX News
20 articles- Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain MitigationYahoo Finance·Apr 29, 2026
- Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026Yahoo Finance·Apr 22, 2026
- Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026Yahoo Finance·Apr 8, 2026
- Autonomix Medical to Present at LSI USA ’26Yahoo Finance·Mar 11, 2026
- Autonomix Medical Selected for Best Innovation Competition at CRT 2026Yahoo Finance·Mar 5, 2026
- Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve NeurolysisYahoo Finance·Mar 4, 2026
- Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific ValidationYahoo Finance·Feb 25, 2026
- Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium PresentationYahoo Finance·Feb 19, 2026
- Autonomix Medical to Present Final Analysis on Pain Mitigation in Pancreatic Cancer at SIO 2026 Annual Scientific MeetingYahoo Finance·Jan 28, 2026
- Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers SymposiumYahoo Finance·Jan 9, 2026
- BC-Most Active StocksYahoo Finance·Dec 30, 2025
- Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in CardiologyYahoo Finance·Dec 30, 2025
- Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect SegmentYahoo Finance·Dec 23, 2025
- Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers SymposiumYahoo Finance·Dec 18, 2025
- Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic GrowthYahoo Finance·Nov 26, 2025
- Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq RulesYahoo Finance·Nov 18, 2025
- Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC StudyYahoo Finance·Nov 17, 2025
- Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific ConferenceYahoo Finance·Oct 24, 2025
- Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth SummitYahoo Finance·Oct 16, 2025
- Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in CardiologyYahoo Finance·Oct 9, 2025
All 20 articles loaded
Price Data
Open$0.39
Previous Close$0.38
Day High$0.39
Day Low$0.38
52 Week High$2.64
52 Week Low$0.32
52-Week Range
$0.32$2.64
$0.38
Fundamentals
Market Cap$4M
P/E Ratio—
EPS$-3.15
Dividend Yield—
Dividend / Share—
ROE-1.9%
Profit Margin—
Debt / Equity—
Trading
Volume85K
Avg Volume (10D)—
Shares Outstanding11.4M
About Autonomix Medical Inc
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company is headquartered in The Woodlands, Texas.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—